Here are articles from the latest issue of American Health & Drug Benefits. AHDB is the peer-reviewed journal for 30,000 decision makers in health plans, PBMs, Medicare, Medicaid, and the pharma and biotech industries:

May 2009 Issue:

The Paradox of Public Policy Reform: Change or Continuum?

By Robert E. Henry

Are You Kidding Me? Clinical Comparative Effectiveness or Evidence-Based Medicine

By Thomas Kaye RPh, MBA, FASHP

MIPPA: First Broad Changes to Medicare Part D Plan Operations

By Jean D. LeMasurier and Babette Edgar, PharmD, MBA

Stakeholder Perspective by Mark Newsom, MSc

ProvenCare: Geisinger’s Model for Care Transformation through Innovative Clinical Initiatives and Value Creation

Interview with Ronald A. Paulus, MD, MBA

Perspective: The Integrated Patient-Centered Medical Home: Tools for Transforming Our Healthcare Delivery System

By Matias A. Klein

Increased Patient Cost-Sharing, Weak US Economy, and Poor Health Habits: Implications for Employers and Insurers

By Melinda C. Haren, RN; Kirk McConnell; Arthur F. Shinn, PharmD, FASCP

Stakeholder Perspective by Paul Anthony Polansky, BSPharm, MBA

New Legislations on Generics and Biosimilars Brewing in Congress

By Dalia Buffery, MA, ABD

Paying for Cancer Care: Economic Models Start to Emerge, Dovetailing Healthcare Reform

By Caroline Helwick

Read Current and Past Issues:

American Health & Drug Benefits (AHDB) is available in print and online at To view the current or past issues, click here.

AHDB also published web exclusives, available for reading here.

Kip Piper is health policy editor of American Health & Drug Benefits.